CooperVision celebrates summer with photo contest

Article

Post your photos to Instagram, then vote for your favorite for a chance to win a weekly prize.

 

Pleasanton, CA-CooperVision invites fans to celebrate summer with its #no2views social media photo contest. During the next 4 weeks, CooperVision will announce a new summer theme on its Facebook page every Monday. Participants need to post an image or photograph on Instagram that best describes their unique view of the theme and include the hashtag #no2views.

Fans can vote for their favorite image via CooperVision’s Facebook page, and the entry with the most “likes” will win one of four weekly prizes, including a movie night package, digital camera, professional photo shoot, or $500 shopping spree, plus where applicable a 6-month supply of CooperVision contact lenses. At the end of the contest, the four weekly winners will be posted on CooperVision’s Facebook page, and the fans will vote for the most unique image overall. The grand prize winner will receive an iPad with Retina Display and where applicable a year’s supply of CooperVision contact lenses.

The #no2views contest will run from July 8, 2013, to August 12, 2013, with winners announced Mondays: July 15, 22, 29, August 5, and the Grand Prize winner announced on August 12.

Recent Videos
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO
Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO
EyeCon Co-chair Oluwatosin U. Smith, MD talks passion for research and education in ophthalmology
Eyerie Academics cofounders discuss the organization's future and preparing optometric students
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO
Sherrol A. Reynolds, OD, speaks about highlights from the 2024 NOA Convention
A. Philip Aitsebaomo, O.D., Ph.D. outlines his talk on treating patients with prosthetic eyes
© 2024 MJH Life Sciences

All rights reserved.